Related Experiment Video
Updated: Apr 21, 2026
11:08
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
1.9K
Are natural killer cells superior CAR drivers?
1Tufts University School of Medicine; Boston, MA USA ; Conkwest Inc.; Cambridge, MA USA.
Oncoimmunology
|October 24, 2014
Summary
Chimeric antigen receptor (CAR) T-cell therapy is a promising cancer treatment. This study explores the potential of CAR-engineered natural killer cells as an alternative immunotherapy, highlighting their advantages.
Area of Science:
- Immunology
- Oncology
- Cell Therapy
Background:
- Chimeric antigen receptor (CAR) T-cell therapy represents a significant advancement in cancer immunotherapy.
- Natural killer (NK) cells, despite their cytotoxic potential, are underutilized as CAR effectors.
Purpose of the Study:
- To investigate the potential of CAR-engineered natural killer cells as an alternative to CAR T-cells in cancer immunotherapy.
- To highlight the advantages associated with using NK cells in CAR-based therapies.
Main Methods:
- Engineering of natural killer cells with chimeric antigen receptors.
- Evaluation of CAR NK cell activity against cancer targets.
- Comparative analysis of CAR NK cells versus CAR T-cells.
Main Results:
- CAR-engineered NK cells demonstrate potent cytotoxic activity.
- NK cells offer potential advantages over T-cells in CAR therapy.
- Further research is warranted to optimize CAR NK cell therapy.
Conclusions:
- CAR-engineered NK cells present a viable and potentially advantageous alternative for cancer immunotherapy.
- Harnessing NK cell properties could overcome limitations of current CAR T-cell therapies.
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:27Cytotoxic T Cells-mediated Immune Response
7.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K
01:28Cells of the Innate Immune Response
8.0K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.0K
01:24T Cell Types and Functions
3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
02:57Targeted Cancer Therapies
6.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
6.9K